Skip to main content

Find Clinical Trials

Home
Conditions
Disease Attributes

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,548 public trials 3,116 recruiting studies

Refine in advanced search Browse all conditions

Disease Attributes trial results

Terminated

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

NCT05581199

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Site Number - 1603 Scottsdale, Arizona, United States

Site Number - 1634 Los Angeles, California, United States

Site Number - 1625 Aurora, Colorado, United States

Site Number - 1621 New Haven, Connecticut, United States

View all 98 locations

View Trial Details

Terminated

An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07188844

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Site Number - 1621 New Haven, Connecticut, United States

Site Number - 1617 Ormond Beach, Florida, United States

Site Number - 1611 Nicholasville, Kentucky, United States

Site Number - 1610 Charlotte, North Carolina, United States

View all 30 locations

View Trial Details

Terminated

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions: Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations: Investigative Site 118 Birmingham, Alabama, United States

Investigative Site 108 Little Rock, Arkansas, United States

Investigative Site 105 San Diego, California, United States

Investigative Site 116 Tampa, Florida, United States

View all 19 locations

View Trial Details

Terminated

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

NCT02075463

Conditions: Anaemia, Anemia, Chronic Disease, +13 more
Locations: GSK Investigational Site Azusa, California, United States

GSK Investigational Site Glendale, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Simi Valley, California, United States

View Trial Details

Suspended

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

NCT06694454

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Withdrawn

Bedside Bike Early Mobilization Program for Inpatients

NCT07281638

Conditions: Cardiovascular Diseases, Confusion, Deep Venous Thrombosis, +19 more
Locations: Not specified

View Trial Details

Withdrawn

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

NCT06597734

Conditions: Advanced Myeloproliferative Neoplasms, Bone Marrow Diseases, Chronic Disease, +13 more
Locations: Not specified

View Trial Details

Withdrawn

Hypoxia and Heart Rate Variability

NCT05606406

Conditions: Chronic Disease, Disease Attributes, Hypoxia, +8 more
Locations: University of Miami Miami, Florida, United States

View Trial Details